Four years after buying exclusive US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker Orexo has terminated the deal. Deprexis is an online cognitive behavioural ...
Over the last 5 years, the share price of Quadrant Future Tek has declined 8.03% CAGR. Over the past year, the corresponding return has been -39.46%. Quadrant Future Tek’s current P/E of -27.79x helps ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results